| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 5,797,889 | 6,071,525 | 5,673,818 | 5,773,570 | | Cost of Revenue | 5,448,616 | 5,748,440 | 5,270,319 | 5,460,397 | | | Gross Profit | 349,273 | 323,085 | 403,499 | 313,173 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 25,415 | 83,367 | 44,584 | 61,698 | | Non Recurring |
-
|
-
| 79,209 | (79,209) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 323,858 | 239,718 | 279,706 | 330,684 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 7,225 | 14,491 | 19,170 | 17,720 | | Earnings Before Interest And Taxes | 331,083 | 254,209 | 298,876 | 348,404 | | Interest Expense | 2,583 | 2,358 | 3,029 | 3,434 | | Income Before Tax | 328,500 | 251,851 | 295,847 | 344,970 | | Income Tax Expense | 107,213 | 61,754 | 112,748 | 135,720 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 221,287 | 190,097 | 183,099 | 209,250 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 221,287 | 190,097 | 183,099 | 209,250 | | Preferred Stock And Other Adjustments | (16,488) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $204,799 | $190,097 | $183,099 | $209,250 |
|
0.45% Nasdaq 0.00%
Income Statement
